Cargando…
The Contribution of High Levels of Somatic Symptom Severity to Sickness Absence Duration, Disability and Discharge
Introduction: The primary objectives were to compare the duration of sickness absence in employees with high levels of somatic symptom severity (HLSSS) with employees with lower levels of somatic symptom severity, and to establish the long-term outcomes concerning return to work (RTW), disability an...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887510/ https://www.ncbi.nlm.nih.gov/pubmed/20373134 http://dx.doi.org/10.1007/s10926-010-9239-3 |
_version_ | 1782182568077033472 |
---|---|
author | Hoedeman, Rob Blankenstein, Annette H. Krol, Boudien Koopmans, Petra C. Groothoff, Johan W. |
author_facet | Hoedeman, Rob Blankenstein, Annette H. Krol, Boudien Koopmans, Petra C. Groothoff, Johan W. |
author_sort | Hoedeman, Rob |
collection | PubMed |
description | Introduction: The primary objectives were to compare the duration of sickness absence in employees with high levels of somatic symptom severity (HLSSS) with employees with lower levels of somatic symptom severity, and to establish the long-term outcomes concerning return to work (RTW), disability and discharge. Secondary objective was to evaluate determinants of the duration of sickness absence in employees with HLSSS. Methods: 489 sick-listed employees registered with five Occupational Health Physician (OHP) group practices were included in this study. We measured their baseline scores for somatic symptoms severity, depressive disorders, anxiety disorders, health anxiety, distress and functional impairment. The OHPs filled in a questionnaire on their diagnosis. A prospective 2-year follow-up was carried out to assess the long-term outcomes concerning sickness absence, and retrospective information was gathered with regard to sickness absence during the 12 months before the employees were sick-listed. Results: The median duration of sickness absence was 78 days longer for employees with HLSSS. They more often remained disabled and were discharged more often, especially due to problems in the relationship between the employer and the employee. HLSSS, health anxiety and older age contributed to a longer duration of sickness absence of employees. Conclusion: High levels of somatic symptom severity are a determinant of prolonged sickness absence, enduring disabilities and health-related job loss. Occupational health physicians should identify employees who are at risk and adhere to guidelines for medically unexplained somatic symptoms. |
format | Text |
id | pubmed-2887510 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-28875102010-07-12 The Contribution of High Levels of Somatic Symptom Severity to Sickness Absence Duration, Disability and Discharge Hoedeman, Rob Blankenstein, Annette H. Krol, Boudien Koopmans, Petra C. Groothoff, Johan W. J Occup Rehabil Article Introduction: The primary objectives were to compare the duration of sickness absence in employees with high levels of somatic symptom severity (HLSSS) with employees with lower levels of somatic symptom severity, and to establish the long-term outcomes concerning return to work (RTW), disability and discharge. Secondary objective was to evaluate determinants of the duration of sickness absence in employees with HLSSS. Methods: 489 sick-listed employees registered with five Occupational Health Physician (OHP) group practices were included in this study. We measured their baseline scores for somatic symptoms severity, depressive disorders, anxiety disorders, health anxiety, distress and functional impairment. The OHPs filled in a questionnaire on their diagnosis. A prospective 2-year follow-up was carried out to assess the long-term outcomes concerning sickness absence, and retrospective information was gathered with regard to sickness absence during the 12 months before the employees were sick-listed. Results: The median duration of sickness absence was 78 days longer for employees with HLSSS. They more often remained disabled and were discharged more often, especially due to problems in the relationship between the employer and the employee. HLSSS, health anxiety and older age contributed to a longer duration of sickness absence of employees. Conclusion: High levels of somatic symptom severity are a determinant of prolonged sickness absence, enduring disabilities and health-related job loss. Occupational health physicians should identify employees who are at risk and adhere to guidelines for medically unexplained somatic symptoms. Springer US 2010-04-07 2010 /pmc/articles/PMC2887510/ /pubmed/20373134 http://dx.doi.org/10.1007/s10926-010-9239-3 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article Hoedeman, Rob Blankenstein, Annette H. Krol, Boudien Koopmans, Petra C. Groothoff, Johan W. The Contribution of High Levels of Somatic Symptom Severity to Sickness Absence Duration, Disability and Discharge |
title | The Contribution of High Levels of Somatic Symptom Severity to Sickness Absence Duration, Disability and Discharge |
title_full | The Contribution of High Levels of Somatic Symptom Severity to Sickness Absence Duration, Disability and Discharge |
title_fullStr | The Contribution of High Levels of Somatic Symptom Severity to Sickness Absence Duration, Disability and Discharge |
title_full_unstemmed | The Contribution of High Levels of Somatic Symptom Severity to Sickness Absence Duration, Disability and Discharge |
title_short | The Contribution of High Levels of Somatic Symptom Severity to Sickness Absence Duration, Disability and Discharge |
title_sort | contribution of high levels of somatic symptom severity to sickness absence duration, disability and discharge |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887510/ https://www.ncbi.nlm.nih.gov/pubmed/20373134 http://dx.doi.org/10.1007/s10926-010-9239-3 |
work_keys_str_mv | AT hoedemanrob thecontributionofhighlevelsofsomaticsymptomseveritytosicknessabsencedurationdisabilityanddischarge AT blankensteinannetteh thecontributionofhighlevelsofsomaticsymptomseveritytosicknessabsencedurationdisabilityanddischarge AT krolboudien thecontributionofhighlevelsofsomaticsymptomseveritytosicknessabsencedurationdisabilityanddischarge AT koopmanspetrac thecontributionofhighlevelsofsomaticsymptomseveritytosicknessabsencedurationdisabilityanddischarge AT groothoffjohanw thecontributionofhighlevelsofsomaticsymptomseveritytosicknessabsencedurationdisabilityanddischarge AT hoedemanrob contributionofhighlevelsofsomaticsymptomseveritytosicknessabsencedurationdisabilityanddischarge AT blankensteinannetteh contributionofhighlevelsofsomaticsymptomseveritytosicknessabsencedurationdisabilityanddischarge AT krolboudien contributionofhighlevelsofsomaticsymptomseveritytosicknessabsencedurationdisabilityanddischarge AT koopmanspetrac contributionofhighlevelsofsomaticsymptomseveritytosicknessabsencedurationdisabilityanddischarge AT groothoffjohanw contributionofhighlevelsofsomaticsymptomseveritytosicknessabsencedurationdisabilityanddischarge |